JYNNEOS vaccine guidelines address how best to distribute state’s limited supply

The Guidelines for JYNNEOS Vaccine Use are designed to ensure that Washington state’s limited supply of JYNNEOS vaccine goes to people who have been exposed to monkeypox virus (MPV) or are at high risk for MPV and that, within those groups, the provision of vaccine is equitable. Changes to the guidance include:

Broadened eligibility

A new diagnosis in the last 12 months of one or more nationally reportable sexually transmitted diseases (i.e., acute HIV, chancroid, chlamydia, gonorrhea, or syphilis.)

Stigma reduction language

While some people at risk for MPV will seek out vaccine, low-barrier access, outreach, and education will be needed to reach all populations at risk and to reduce disparities in vaccine uptake (and therefore disease incidence). Utilizing a checklist to validate eligibility may cause stigmatization and should not be used. This is especially important to make vaccine more accessible to individuals who have not chosen to disclose their sexual orientation to others.

You can find this guidance and additional resources on DOH’s Monkeypox (MPV) Provider FAQs and Resources page.